PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)

Stopped Sponsor's prerogative since initial purpose for study shifted according to business strategy.

Conditions

• Primary Open-angle Glaucoma

Interventions

• DRUG: PRO-122
• DRUG: Timolol eye drops
• DRUG: Dorzolamide-Timolol Ophthalmic
• DRUG: Brimonidine Ophthalmic Solution
• OTHER: Placebo1
• OTHER: Placebo 2
• DRUG: Krytantek

Sponsor

Laboratorios Sophia S.A de C.V.